Please use this identifier to cite or link to this item:
https://ir.swu.ac.th/jspui/handle/123456789/14896| Title: | Plasma levels, safety, and 60-week efficacy of a once-daily double-boosted protease inhibitor regimen of atazanavir, saquinavir, and ritonavir |
| Authors: | Manosuthi W. Sungkanuparph S. Ruxrungtham K. Prasithsirikul W. Athichathanabadi C. Tantisiriwat W. Bowonwatanuwong C. Chumpathat N. Chaovavanich A. |
| Keywords: | atazanavir proteinase inhibitor ritonavir RNA directed DNA polymerase inhibitor saquinavir virus RNA atazanavir oligopeptide proteinase inhibitor pyridine derivative ritonavir saquinavir adult aminotransferase blood level blood sampling CD4 lymphocyte count clinical article controlled study DNA polymorphism drug blood level drug efficacy drug safety drug tolerability dyslipidemia female high performance liquid chromatography human Human immunodeficiency virus infection hyperbilirubinemia letter low drug dose male practice guideline priority journal salvage therapy side effect steady state treatment duration treatment outcome virus resistance article drug administration drug combination Drug Administration Schedule Drug Therapy, Combination HIV Infections HIV Protease Inhibitors Humans Oligopeptides Pyridines Ritonavir Saquinavir |
| Issue Date: | 2008 |
| Abstract: | [No abstract available] |
| URI: | https://ir.swu.ac.th/jspui/handle/123456789/14896 https://www.scopus.com/inward/record.uri?eid=2-s2.0-39049117418&doi=10.1097%2fQAI.0b013e318157b0da&partnerID=40&md5=9c6cb1be2c5626aefcfeb310a21297cf |
| ISSN: | 15254135 |
| Appears in Collections: | Scopus 1983-2021 |
Files in This Item:
There are no files associated with this item.
Items in SWU repository are protected by copyright, with all rights reserved, unless otherwise indicated.